After the initial fracture in postmenopausal women, where do subsequent fractures occur?

[1]  N. Watts,et al.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS-2020 UPDATE. , 2020, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[2]  R. Desai,et al.  Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures: An Instrumental Variable Analysis. , 2018, JAMA network open.

[3]  M. Phipps,et al.  Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement , 2018, JAMA.

[4]  A. Qaseem,et al.  Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians. , 2017, Annals of internal medicine.

[5]  C. Cooper,et al.  Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures , 2017, Osteoporosis International.

[6]  H. Mogun,et al.  Impact of the U.S. Food and Drug Administration's Safety‐Related Announcements on the Use of Bisphosphonates After Hip Fracture , 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  T. Tosteson,et al.  Second fractures among older adults in the year following hip, shoulder, or wrist fracture , 2016, Osteoporosis International.

[8]  J. Cauley,et al.  Wrist Fracture and Risk of Subsequent Fracture: Findings from the Women's Health Initiative Study , 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  E. M. Lewiecki,et al.  Clinician’s Guide to Prevention and Treatment of Osteoporosis , 2014, Osteoporosis International.

[10]  J. Ullal,et al.  Osteoporosis treatment disparities: a 6-year aggregate analysis from national survey data , 2014, Osteoporosis International.

[11]  D. Wysowski,et al.  Trends in osteoporosis treatment with oral and intravenous bisphosphonates in the United States, 2002-2012. , 2013, Bone.

[12]  J. Eisman,et al.  Progressively increasing fracture risk with advancing age after initial incident fragility fracture: The Tromsø Study , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  U. P. S. T. Force,et al.  Screening for Osteoporosis: U.S. Preventive Services Task Force Recommendation Statement , 2011, Annals of Internal Medicine.

[14]  Barbara E Ainsworth,et al.  Evaluation of physical activity measures used in middle-aged women. , 2009, Medicine and science in sports and exercise.

[15]  D. Siscovick,et al.  Test-retest reliability of the Women's Health Initiative physical activity questionnaire. , 2009, Medicine and science in sports and exercise.

[16]  L. Markson,et al.  Wrist fracture as a predictor of future fractures in younger versus older postmenopausal women: results from the National Osteoporosis Risk Assessment (NORA) , 2008, Osteoporosis International.

[17]  A. LaCroix,et al.  Validity of self-report for fractures among a multiethnic cohort of postmenopausal women: results from the Women's Health Initiative observational study and clinical trials , 2004, Menopause.

[18]  R. Langer,et al.  The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. , 2003, Annals of epidemiology.

[19]  A. Kristal,et al.  Measurement characteristics of the Women's Health Initiative food frequency questionnaire. , 1999, Annals of epidemiology.

[20]  E. Andresen,et al.  Test-retest performance of a mailed version of the Medical Outcomes Study 36-Item Short-Form Health Survey among older adults. , 1996, Medical care.

[21]  N. Ghannam,et al.  Book review: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. , 1994, Annals of Saudi medicine.

[22]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[23]  D. Kiel,et al.  Addressing the Crisis in the Treatment of Osteoporosis: A Path Forward. , 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  JoAnn E. Manson,et al.  Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. , 1998, Controlled clinical trials.

[25]  Claus Christiansen,et al.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. , 1994, World Health Organization technical report series.